Francois Vigneault, departing Shape Therapeutics CEO
October 17, 2024 01:16 PM EDT
People
Startups
Cell/Gene Tx

RNA gene ther­a­py start­up Shape hunts for new CEO as Se­ries C awaits

Kyle LaHucik

Senior Reporter

Shape Ther­a­peu­tics CEO Fran­cois Vi­gneault has de­part­ed the RNA gene ther­a­py start­up, and chief sci­en­tif­ic of­fi­cer David Huss is fill­ing the post while the Seat­tle …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

Will CRISPR mat­ter?

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times